Ureteral Stenting After Ureteroscopy for Stone Treatment, A Global Perspective on Indications and Outcomes

Completed

Conditions studied: Stone;Renal, Stone, Kidney, Stone Ureter

In brief

Background: The exit strategy after ureteroscopy for stone treatment remains a topic for discussion. Current EAU guidelines on urolithiasis state that postoperative stenting is indicated in patients at increased risk of postoperative complications. Stenting is not considered necessary in all other cases, and after uncomplicated procedures. Objective: To analyse the postoperative ureteral stenting strategy in clinical practice looking at the indication, type of stents used and the duration of stenting after ureteroscopy for stone treatment. Furthermore, the investigators will examine in what setting the stents are being removed postoperatively. Study design: This study is a prospective, observational, international, multicentre registry study executed by uCARE. Study population: All patients \>18 years with a ureter or renal stone who are planned for ureteroscopic treatment by semi-rigid and/or flexible ureteroscopy are eligible for this study.

Key facts

Study ID

NCT03567421

Run by

Société Internationale d'Urologie

People needed

2348

Starts

2018-06-07

Expected to finish

2019-08-31

Last updated by the study team

2021-04-13

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patient >18 years old
• Patient is a candidate for ureteroscopic treatment of a ureter or renal stone by semi-rigid and/or flexible ureteroscopy

You may not qualify if…

• Patient <18 years old

Where it is running

• University of Minnesota — Minneapolis, Minnesota, United States
• Guangdong Second Provincial General Hospital, The Third Clinical Medical College of Southern Medical University — Guangzhou, Guangdong, China
• The First Affiliated Hospital of Guangzhou Medical University and Guangdong Key Laboratory of Urology — Guangzhou, China
• Ningbo First Hospital, The Affiliated Hospital of Ningbo University — Ningbo, China
• Renji Hospital, School of Medicine, Shanghai Jiao Tong University — Shanghai, China
• Shanghai Changhai Hospital, Second Military Medical University — Shanghai, China
• Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology — Wuhan, China
• Aretaieion Hospital — Athens, Greece
• Sismanoglio General Hospital — Athens, Greece
• University of Crete, Department of Urology — Heraklion, Greece
• Department of Urology, University Hospital of Larissa — Larissa, Greece
• 1st Department of Urology, Aristotle University — Thessaloniki, Greece
• Jawahar Lal Nehru (JLN) Medical College — Ajmer, Rajasthan, India
• Kulkarni Reconstructive Urology Center — Pune, India
• Department of Urology, Hasan Sadikin Hospital/Padjadjaran University — Bandung, Indonesia
• Department of Urology, Sanglah Hospital/Udayana University — Denpasar, Indonesia
• Department of Urology, Cipto Mangunkusumo Hospital/University of Indonesia — Jakarta, Indonesia
• Department of Urology, Saiful Anwar Hospital/Brawijaya University — Malang, Indonesia
• Department of Urology, Dr. Soetomo Hospital/Airlangga University — Surabaya, Indonesia
• Department of Urology, Sardjito Hospital/Gadjah Mada University — Yogyakarta, Indonesia
• Shahid Beheshti Hospital, Hamadan University of Medical Sciences — Hamadan, Iran
• University of Basra, College of Medicine, Urology Department — Basra, Iraq
• Pandya Memorial Hospital — Mombasa, Kenya
• Selayang Hospital — Batu Caves, Malaysia
• Serdang Hospital — Kajang, Malaysia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.